Kasner, S. E., Swaminathan, B., Lavados, P., Sharma, M., Muir, K., Veltkamp, R., . . . Hart, R. G. (2018). Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: A prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol.
Chicago Style citaatKasner, Scott E., et al. "Rivaroxaban or Aspirin for Patent Foramen Ovale and Embolic Stroke of Undetermined Source: A Prespecified Subgroup Analysis From the NAVIGATE ESUS Trial." Lancet Neurol 2018.
MLA citatieKasner, Scott E., et al. "Rivaroxaban or Aspirin for Patent Foramen Ovale and Embolic Stroke of Undetermined Source: A Prespecified Subgroup Analysis From the NAVIGATE ESUS Trial." Lancet Neurol 2018.
Let op: Deze citaties zijn niet altijd 100% accuraat.